Advertisement
Home »

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Mar 22, 2023

REFERENCES & ADDITIONAL READING

Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

https://diabetesjournals.org/care/article-abstract/46/2/377/148065/Concomitant-Use-of-Sulfonylureas-and-Blockers-and?redirectedFrom=fulltext

ABOUT THE EXPERTS

  • Antonios Douros, MD
    Department of Medicine, McGill University
    Centre for Clinical Epidemiology, Lady Davis Institute
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University
    Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin

    Antonio Douros, MD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

     

    Jenny Dimakos, MD-candidate
    Department of Medicine
    McGill University

    Jenny Dimakos, MD-candidate, has indicated to Physician’s Weekly that she has no financial interests to disclose.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement